EDUCATION

Bridging the Radiotherapy Education Gap

A meaningful share of the global cancer burden traces back to a small set of infectious agents — and that means meaningful prevention is within reach.
Download PDF (2.4 MB)

Infection-attributable cancers continue to account for a sizeable share of the global cancer burden, with the heaviest impact concentrated in regions that already face the greatest barriers to diagnosis and treatment.

Mapping the Burden

Recent population-level analyses make clear that a small number of infectious agents are responsible for most preventable cancer cases worldwide. The geography of that burden tracks closely with vaccine coverage, screening availability, and access to early treatment.

Translating this evidence into action means closing well-understood gaps — not waiting for new science.

The interventions that would prevent most of these cancers already exist. The challenge is deployment, not discovery.

Practical Prevention

Vaccination programmes, simple screening protocols, and timely treatment of precursor conditions are the levers that move the numbers. Progress depends on aligning health-system capacity, public-health communication, and sustainable financing.

Lead Authors

Jose M. Martin-Moreno, MD, PhD

Jose M. Martin-Moreno, MD, PhD

SENIOR ESMO PUBLIC POLICY COMMITTEE

Received his medical and public health education and training from the University of Granada (Spain) and Harvard University (USA). His main speciality is preventive medicine and public health, with particular emphasis on health policy and cancer control.

Eduardo Cazap, MD, PhD, FASCO

Eduardo Cazap, MD, PhD, FASCO

DEPUTY CHAIR, ESMO EMERGING COUNTRIES COMMITTEE

Founder and first President of the Latin American and Caribbean Society of Medical Oncology (SLACOM). Immediate Past President of the Union for International Cancer Control (UICC-Geneva) and member of the Executive Committee of the National Cancer Institute of Argentina.